Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,305,230
+$2,076,638 QoQ
Shares Held
56,848
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#757
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. ABBV ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,305,230 | 56,848 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,228,592 | 56,226 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,312,640 | 53,887 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,583,504 | 54,347 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,783,658 | 52,708 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,152,749 | 53,230 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,135,803 | 34,529 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,934,115 | 35,113 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,065,633 | 35,364 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,289,916 | 34,541 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,161,740 | 33,308 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,437,665 | 29,771 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,756,137 | 27,879 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,579,496 | 28,735 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,351,187 | 26,924 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,338,742 | 24,877 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,391,575 | 22,144 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,600,463 | 22,210 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,880,635 | 21,275 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,541,354 | 14,289 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,590,251 | 14,118 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,478,068 | 13,658 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,399,271 | 13,059 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,147,078 | 13,096 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,476,038 | 15,034 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,418,924 | 18,624 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||